Skip to content
Menu Close
Close button
Go back to News

Novartis Inks Deal with Covalent Medicines Biotech Matchpoint for $60M Upfront

Matchpoint_News
Access Industries
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.